PacBio Ships First Vega Systems To Berry Genomics For Clinical Assay Development In Asian Markets, With Plans For NMPA Regulatory Approval And Over 50 Additional Units Committed
PacBio Ships First Vega Systems To Berry Genomics For Clinical Assay Development In Asian Markets, With Plans For NMPA Regulatory Approval And Over 50 Additional Units Committed
PacBio向貝瑞基因交付首批Vega系統，用於亞太市場的臨牀檢測開發，計劃申請NMPA監管批准，並承諾提供超過50台額外設備。
PacBio Ships First Vega Systems To Berry Genomics For Clinical Assay Development In Asian Markets, With Plans For NMPA Regulatory Approval And Over 50 Additional Units Committed
PacBio向貝瑞基因交付首批Vega系統，用於亞太市場的臨牀檢測開發，計劃申請NMPA監管批准，並承諾提供超過50台額外設備。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。